工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.
Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
B 细胞在免疫中发挥重要作用,主要通过产生高亲和力浆细胞(PC)和记忆 B(Bmem)细胞。B 细胞的亲和力成熟和分化依赖于分别由抗原结合和微环境提供的 B 细胞受体(BCR)内在信号和外在信号的整合。近年来,肿瘤浸润 B(TIL-B)细胞和 PC(TIL-PC)已被揭示为人类癌症抗肿瘤反应中的重要参与者,但它们之间的相互作用和动态在很大程度上仍不清楚。在淋巴器官中,B 细胞反应涉及依赖生发中心(GC)和不依赖 GC 的途径来产生 Bmem 细胞和 PC。BCR 库的亲和力成熟发生在 GC 反应中,B 细胞信号整合具有特定的时空动态。一般来说,高亲和力 Bmem 细胞被抗原再激活会触发不依赖 GC 的大量 PC 产生,而无需 BCR 再多样化。理解免疫反应中 B 细胞的动态需要整合多种工具和读数,如单细胞表型分析和 RNA-seq、原位分析、BCR 库分析、BCR 特异性和亲和力测定以及功能测试。
在此,我们综述了这些工具近年来如何被应用于研究不同类型实体瘤中的 TIL-B 细胞和 TIL-PC。我们评估了已发表的证据,涉及 TIL-B 细胞动态的不同模型,包括依赖 GC 或不依赖 GC 的局部反应以及由此产生的抗原特异性 PC。
总之,我们强调需要更多整合性 B 细胞免疫学研究,以理性地研究 TIL-B 细胞作为抗肿瘤治疗的杠杆。
B cells play essential roles in immunity, mainly through the production of high affinity plasma cells (PCs) and memory B (Bmem) cells. The affinity maturation and differentiation of B cells rely on the integration of B-cell receptor (BCR) intrinsic and extrinsic signals provided by antigen binding and the microenvironment, respectively. In recent years, tumor infiltrating B (TIL-B) cells and PCs (TIL-PCs) have been revealed as important players in antitumor responses in human cancers, but their interplay and dynamics remain largely unknown.
In lymphoid organs, B-cell responses involve both germinal center (GC)-dependent and GC-independent pathways for Bmem cell and PC production. Affinity maturation of BCR repertoires occurs in GC reactions with specific spatiotemporal dynamics of signal integration by B cells.
In general, the reactivation of high-affinity Bmem cells by antigens triggers GC-independent production of large numbers of PC without BCR rediversification. Understanding B-cell dynamics in immune responses requires the integration of multiple tools and readouts such as single-cell phenotyping and RNA-seq, in situ analyses, BCR repertoire analysis, BCR specificity and affinity assays, and functional tests.
Here, we review how those tools have recently been applied to study TIL-B cells and TIL-PC in different types of solid tumors.
We assessed the published evidence for different models of TIL-B-cell dynamics involving GC-dependent or GC-independent local responses and the resulting production of antigen-specific PCs. Altogether, we highlight the need for more integrative B-cell immunology studies to rationally investigate TIL-B cells as a leverage for antitumor therapies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。